scholarly article | Q13442814 |
P50 | author | Anne B. Newman | Q21401975 |
Howard D Strickler | Q89146137 | ||
Swapnil Rajpathak | Q92544163 | ||
Aileen P McGinn | Q117248711 | ||
Bruce M. Psaty | Q30429993 | ||
Elsa S. Strotmeyer | Q42639734 | ||
Anne Cappola | Q88050382 | ||
Lewis Kuller | Q88077314 | ||
P2093 | author name string | Robert C Kaplan | |
Michael Pollak | |||
Thomas E Rohan | |||
XiaoNan Xue | |||
P2860 | cites work | Provision or distribution of growth hormone for "antiaging": clinical and legal issues | Q28279021 |
The Cardiovascular Health Study: design and rationale | Q29614874 | ||
Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus | Q29616284 | ||
Insulin-like growth factors (IGFs): implications for aging | Q35149804 | ||
Serum levels of insulin-like growth factor I and its binding proteins in health and disease | Q35197911 | ||
Free insulin-like growth factors -- measurements and relationships to growth hormone secretion and glucose homeostasis | Q35874079 | ||
Molecular interactions of the IGF system | Q36152450 | ||
Aging somatotropic axis: mechanisms and implications of insulin-like growth factor-related binding protein adaptation | Q36323530 | ||
Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study | Q38487837 | ||
Stimulation of insulin-like growth factor binding protein-1 synthesis by interleukin-1beta: requirement of the mitogen-activated protein kinase pathway | Q40857963 | ||
Insulin-like growth factor binding protein-1: recent findings and new directions. | Q41663650 | ||
Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity | Q43596024 | ||
No decrease in free IGF-I with increasing insulin in obesity-related insulin resistance | Q43763142 | ||
Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study | Q44017895 | ||
Free and total insulin-like growth factor (IGF)-I levels decline during fasting: relationships with insulin and IGF-binding protein-1. | Q44018225 | ||
Family history of type 2 diabetes is associated with decreased insulin sensitivity and an impaired balance between insulin sensitivity and insulin secretion in white youth | Q45199384 | ||
Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance | Q45199388 | ||
A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction | Q45262915 | ||
Altered response of insulin-like growth factor-binding protein 1 to nutritional deprivation in type 2 diabetes mellitus | Q45286373 | ||
Role of insulin-like growth factor iin maintaining normal glucose homeostasis | Q46371076 | ||
Maternal plasma concentrations of IGF-1, IGFBP-1, and C-peptide in early pregnancy and subsequent risk of gestational diabetes mellitus | Q46783769 | ||
The impact of abnormalities in IGF and inflammatory systems on the metabolic syndrome | Q47627541 | ||
Choice of treatment affects plasma levels of insulin-like growth factor-binding protein-1 in noninsulin-dependent diabetes mellitus | Q47645417 | ||
Metabolic, anthropometric, and nutritional factors as predictors of circulating insulin-like growth factor binding protein-1 levels in middle-aged and elderly men. | Q47799021 | ||
Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke | Q48797065 | ||
Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1. | Q49083892 | ||
Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. | Q51559519 | ||
Effects of recombinant human insulin-like growth factor I (IGF-I) therapy on the growth hormone-IGF system of a patient with a partial IGF-I gene deletion. | Q51563594 | ||
Free insulin-like growth factors in human obesity. | Q51585625 | ||
Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. | Q51594172 | ||
Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. | Q51598608 | ||
High-calorie total parenteral nutrition reduces hepatic insulin-like growth factor-I mRNA and alters serum levels of insulin-like growth factor-binding protein-1, -3, -5, and -6 in the rat. | Q53884376 | ||
Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. National Diabetes Data Group | Q66972631 | ||
Insulin-like growth factor-binding protein-1 modulates blood glucose levels | Q67700946 | ||
Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor | Q71597507 | ||
Laboratory methods and quality assurance in the Cardiovascular Health Study | Q72588345 | ||
Regulation of IGF binding protein-1 in hep G2 cells by cytokines and reactive oxygen species | Q74590968 | ||
Insulin-like growth factor binding protein-1 in NIDDM: relationship with the insulin resistance syndrome | Q77969663 | ||
Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke | Q79691420 | ||
The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease | Q81024332 | ||
Diagnosis and classification of diabetes mellitus | Q82064791 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | glucose intolerance | Q2661464 |
P304 | page(s) | 166-173 | |
P577 | publication date | 2007-09-27 | |
P1433 | published in | Growth Hormone & I G F Research | Q15766227 |
P1476 | title | Insulin-like growth factor-(IGF)-axis, inflammation, and glucose intolerance among older adults | |
P478 | volume | 18 |
Q34153541 | Association between serum IGF-1 and diabetes among U.S. adults. |
Q43202934 | Associations between plasma insulin-like growth factor-I and the markers of inflammation interleukin 6, C-reactive protein and YKL-40 in an elderly background population |
Q35626194 | Changes in insulin-like growth factor-I and its binding proteins are associated with diabetes mellitus in older adults |
Q34310978 | Circulating IGF-axis protein levels and their relation with levels of plasma adipocytokines and macronutrient consumption in women |
Q47754986 | Comparison of Intermittent Fasting Versus Caloric Restriction in Obese Subjects: A Two Year Follow-Up |
Q88993170 | Composition and richness of the serum microbiome differ by age and link to systemic inflammation |
Q46200583 | Effect of obesity and glycemic control on serum lipocalins and insulin-like growth factor axis in type 2 diabetic patients |
Q34018992 | IGF-binding protein 1 and abdominal obesity in the development of type 2 diabetes in women |
Q35857746 | Increasing circulating IGFBP1 levels improves insulin sensitivity, promotes nitric oxide production, lowers blood pressure, and protects against atherosclerosis |
Q35953962 | Insulin-Like Growth Factor 1 (IGF-1) in Parkinson's Disease: Potential as Trait-, Progression- and Prediction Marker and Confounding Factors |
Q98465736 | Insulin-Like Growth Factor Gene Polymorphisms Predict Clinical Course in Allogeneic Hematopoietic Stem Cell Transplantation |
Q36182551 | Insulin-like growth factor axis and risk of type 2 diabetes in women |
Q37887276 | Insulin-like growth factor pathway: a link between androgen deprivation therapy (ADT), insulin resistance, and disease progression in patients with prostate cancer? |
Q46581854 | Insulin-like growth factor-binding protein-1 in the prediction and development of type 2 diabetes in middle-aged Swedish men. |
Q35409283 | Insulin-like growth factors and leukocyte telomere length: the cardiovascular health study |
Q33736071 | Leukocyte telomere length associates with prospective mortality independent of immune-related parameters and known genetic markers |
Q36029231 | Metabolic actions of insulin-like growth factor-I in normal physiology and diabetes |
Q50451678 | Oolong, black and pu-erh tea suppresses adiposity in mice via activation of AMP-activated protein kinase. |
Q33791812 | Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741. |
Q42880651 | RTEF-1 attenuates blood glucose levels by regulating insulin-like growth factor binding protein-1 in the endothelium |
Q36842127 | Reciprocal association of plasma IGF-1 and interleukin-6 levels with cardiometabolic risk factors in nondiabetic subjects |
Q37269401 | Role of IGF-1 in glucose regulation and cardiovascular disease |
Q33559252 | Serum IGF-I and C-reactive protein in healthy black and white young men: the CARDIA male hormone study |
Q37408256 | Serum insulin-like growth factor-1 binding proteins 1 and 2 and mortality in older adults: the Health, Aging, and Body Composition Study |
Q47639338 | The Association Between IGF-I and IGFBP-3 and Incident Diabetes in an Older Population of Men and Women in the Cardiovascular Health Study |
Q35747222 | The IGF-I regulatory system and its impact on skeletal and energy homeostasis |
Q58568638 | The insulin like growth factor and binding protein family: Novel therapeutic targets in obesity & diabetes |
Q34127704 | The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes |
Q51822595 | Wanted: guidelines for reporting correlations. |
Search more.